Open AccessIntensity modulated radiotherapy in anal canal squamous cell carcinoma: Implementation and outcomes
Author(s) -
Avipsa Das,
Moses Arunsingh,
Tapesh Bhattacharyya,
Sriram Prasath,
B Arun,
Indranil Mallick
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_212_19
Subject(s) - medicine , proctitis , anal carcinoma , anal cancer , mucositis , radiation therapy , anal canal , chemoradiotherapy , chemotherapy , stage (stratigraphy) , surgery , oncology , gastroenterology , rectum , cancer , disease , ulcerative colitis , paleontology , biology
Concurrent chemoradiotherapy (CCRT) is the standard curative treatment option for nonmetastatic anal squamous cell carcinoma (SCC). Intensity modulated radiotherapy (IMRT) can reduce doses delivered to bowel and skin and reduce toxicities associated with conventional fields. Here, we present our institutional data on dosimetry, toxicity, and clinical outcomes with IMRT for anal cancer.